Related Experiment Videos
High-dose intravenous gammaglobulin therapy for uveitis
1Department of Ophthalmology, Mitsubishi-Kyoto-Hospital, Japan.
Metabolic, Pediatric, and Systemic Ophthalmology (New York, N.Y. : 1985)
|January 1, 1989
Summary
Intravenous gammaglobulin therapy effectively treated severe uveitis, resolving retinal inflammation and improving vision when steroids failed. This offers a new treatment option for complex uveitis cases.
Area of Science:
- Ophthalmology
- Immunology
Background:
- Severe uveitis can lead to significant vision loss.
- Retinal phlebitis, exudation, and vitreous hemorrhage are serious complications of uveitis.
- High-dose steroid therapy is a common treatment for severe uveitis.
Observation:
- A patient with severe uveitis experienced persistent retinal phlebitis, exudation, and vitreous bleeding despite high-dose steroid treatment.
- Intravenous gammaglobulin (IVIG) therapy was administered to this patient.
Findings:
- Following IVIG administration, the patient's retinal exudation and phlebitis significantly subsided.
- The patient experienced a dramatic increase in visual acuity after IVIG treatment.
Implications:
- Intravenous gammaglobulin therapy may be a viable and effective treatment for severe uveitis refractory to steroid therapy.
- This case highlights the potential of immunomodulatory therapies in managing complex ocular inflammatory conditions.
- Further research into IVIG for uveitis is warranted to confirm these findings and establish treatment protocols.